SALIX PHARMACEUTICALS, LTD.

Inactive Instrument

Salix Pharmaceuticals, Ltd. Share Price

Equities

US7954351067

Pharmaceuticals

Chart Salix Pharmaceuticals, Ltd.

Duration

Period

Style

Latest news about Salix Pharmaceuticals, Ltd.

Endo : Valeant trumps Endo with $10.96 billion bid for Salix Pharma	17/03/15	RE
Bank of Montreal : TSX climbs on upbeat sentiment ahead of Fed meeting	16/03/15	RE
Wall St. bounces as dollar drops, Fed worries ease	16/03/15	RE
Endo : withdraws offer for Salix	16/03/15	RE
Valeant Pharmaceuticals Intl : TSX rebounds as energy shares advance with oil price	11/03/15	RE
AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	05/03/15	RE
AbbVie : Biotech buys get pharma M&A off to flying start in 2015	05/03/15	RE
AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	05/03/15	RE
Shire : buys Meritage Pharma for at least $70 million	24/02/15	RE
Canadian Natural Resources : TSX gains on Valeant news; financial stocks weigh	23/02/15	RE
Boeing : Nasdaq ends up 9th session; S&P 500, Dow dip with energy	23/02/15	RE
BioMarin Pharmaceutical : Exclusive - Rare disease drugmaker PTC Therapeutics explores sale: sources	23/02/15	RE
Salix Pharmaceuticals : Valeant nears deal to buy Salix for about $10 billion - WSJ	21/02/15	RE
Barrick Gold : TSX steady as bank shares offset Valeant gain	20/02/15	RE
Endo : Drugmaker Valeant close to buying Salix - source	20/02/15	RE

Press releases Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals : Confirms Receipt of an Unsolicited Proposal from Endo International plc	11/03/15	BU
Salix Pharmaceuticals : Reports 4Q2014 and FY2014 Results	02/03/15	BU
Salix Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	27/02/15	PR
Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5% Convertible Senior Notes Due 2019	25/02/15	BU
Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75% Convertible Senior Notes Due 2015	25/02/15	BU

More press releases

News in other languages on Salix Pharmaceuticals, Ltd.

Valeant Pharmaceuticals Intl : Le laboratoire canadien Valeant conclut l'acquisition de Salix	01/04/15
Le recul du dollar a favorisé le rebond de Wall Street	16/03/15
Allergan : Valeant relève son offre sur Salix, Endo jette l'éponge	16/03/15
BlackBerry : Les valeurs à suivre sur les marchés américains	16/03/15
Valeant Pharmaceuticals Intl : La nouvelle offre de Valeant sur Salix proche de $170 par action-source	14/03/15

Managers and Directors - Salix Pharmaceuticals, Ltd.

Managers	Title	Age	Since
Robert Spurr PSD	President	-	-
John Temperato SAM	Sales & Marketing	59	-

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
MERCK KGAA	+4.06%	70.44B
KYOWA KIRIN CO. LTD.	+10.97%	8.94B
SK BIOPHARMACEUTICALS CO., LTD.	-16.83%	4.75B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43.48%	4.5B
YUHAN CORPORATION	+3.20%	3.85B
INDIVIOR PLC	+23.46%	2.38B
BETTA PHARMACEUTICALS CO., LTD.	-21.36%	2.34B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-27.04%	2.2B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+7.97%	1.96B

Specialty & Advanced Pharmaceuticals

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer